StockData
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) stock

KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.43−0.07 (-13.14%)

Close on Nov 17, 2026Market cap $14.51MP/E –Yield –

Pasithea Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Pasithea Therapeutics's enterprise value was -$27.89M on Nov 11, 2026, against $6.82M a year earlier. Over the last 5 years it ranged from -$39.12M to $6.82M, with a median of -$12.89M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$27.89M-609.0%
2025Dec 31, 2025$5.48M–
2024Dec 31, 2024-$6.07M–
2023Dec 29, 2023-$11.97M–
2022Dec 30, 2022-$25.34M-1000.8%
2021Dec 31, 2021$2.81M–

More Pasithea Therapeutics figures

See a number that looks wrong?